Literature DB >> 25765509

Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.

David W Roberts1, Anne Marie Api2, Robert J Safford3, Jon F Lalko4.   

Abstract

An essential step in ensuring the toxicological safety of chemicals used in consumer products is the evaluation of their skin sensitising potential. The sensitising potency, coupled with information on exposure levels, can be used in a Quantitative Risk Assessment (QRA) to determine an acceptable level of a given chemical in a given product. Where consumer skin exposure is low, a risk assessment can be conducted using the Dermal Sensitisation Threshold (DST) approach, avoiding the need to determine potency experimentally. Since skin sensitisation involves chemical reaction with skin proteins, the first step in the DST approach is to assess, on the basis of the chemical structure, whether the chemical is expected to be reactive or not. Our accompanying publication describes the probabilistic derivation of a DST of 64 μg/cm(2) for chemicals assessed as reactive. This would protect against 95% of chemicals assessed as reactive, but the remaining 5% would include chemicals with very high potency. Here we discuss the chemical properties and structural features of high potency sensitisers, and derive an approach whereby they can be identified and consequently excluded from application of the DST.
Copyright © 2015 Elsevier Inc. All rights reserved.

Keywords:  Dermal Sensitisation Threshold (DST); High Potency Category Chemicals (HPC); Local Lymph Node Assay (LLNA); Non-animal methods; Sensitisation risk assessment; Skin sensitisation; Structure alerts

Mesh:

Substances:

Year:  2015        PMID: 25765509     DOI: 10.1016/j.yrtph.2015.03.001

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  3 in total

1.  Skin sensitization in silico protocol.

Authors:  Candice Johnson; Ernst Ahlberg; Lennart T Anger; Lisa Beilke; Romualdo Benigni; Joel Bercu; Sol Bobst; David Bower; Alessandro Brigo; Sarah Campbell; Mark T D Cronin; Ian Crooks; Kevin P Cross; Tatyana Doktorova; Thomas Exner; David Faulkner; Ian M Fearon; Markus Fehr; Shayne C Gad; Véronique Gervais; Amanda Giddings; Susanne Glowienke; Barry Hardy; Catrin Hasselgren; Jedd Hillegass; Robert Jolly; Eckart Krupp; Liat Lomnitski; Jason Magby; Jordi Mestres; Lawrence Milchak; Scott Miller; Wolfgang Muster; Louise Neilson; Rahul Parakhia; Alexis Parenty; Patricia Parris; Alexandre Paulino; Ana Theresa Paulino; David W Roberts; Harald Schlecker; Reinhard Stidl; Diana Suarez-Rodrigez; David T Szabo; Raymond R Tice; Daniel Urbisch; Anna Vuorinen; Brian Wall; Thibaud Weiler; Angela T White; Jessica Whritenour; Joerg Wichard; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Regul Toxicol Pharmacol       Date:  2020-07-01       Impact factor: 3.271

2.  Implementation of In Silico Toxicology Protocols in Leadscope.

Authors:  Kevin Cross; Candice Johnson; Glenn J Myatt
Journal:  Methods Mol Biol       Date:  2022

3.  Interpretation of murine local lymph node assay (LLNA) data for skin sensitization: Overload effects, danger signals and chemistry-based read-across.

Authors:  David W Roberts
Journal:  Curr Res Toxicol       Date:  2021-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.